Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study - Supplement

Supplemental material for manuscript published in the Journal for the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2021.05.05